Alan A. Wilson

24.5k total citations · 3 hit papers
328 papers, 19.0k citations indexed

About

Alan A. Wilson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan A. Wilson has authored 328 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Cellular and Molecular Neuroscience, 103 papers in Molecular Biology and 72 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan A. Wilson's work include Neurotransmitter Receptor Influence on Behavior (121 papers), Neuroscience and Neuropharmacology Research (84 papers) and Medical Imaging Techniques and Applications (57 papers). Alan A. Wilson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (121 papers), Neuroscience and Neuropharmacology Research (84 papers) and Medical Imaging Techniques and Applications (57 papers). Alan A. Wilson collaborates with scholars based in Canada, United States and United Kingdom. Alan A. Wilson's co-authors include Sylvain Houle, Jeffrey H. Meyer, Nathalie Ginovart, Pablo Rusjan, Shitij Kapur, Doug Hussey, Romina Mizrahi, Hayden T. Ravert, Robert F. Dannals and Henry N. Wagner and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Alan A. Wilson

321 papers receiving 18.5k citations

Hit Papers

Role of Translocator ... 1984 2026 1998 2012 2015 1986 1984 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan A. Wilson Canada 75 8.3k 4.4k 3.8k 3.3k 3.1k 328 19.0k
Robert B. Innis United States 84 10.6k 1.3× 6.5k 1.5× 4.0k 1.0× 3.8k 1.1× 2.9k 0.9× 412 25.7k
Christer Halldin Sweden 75 9.5k 1.1× 6.7k 1.5× 4.1k 1.1× 3.7k 1.1× 2.8k 0.9× 668 24.1k
Marc Laruelle United States 75 12.2k 1.5× 5.3k 1.2× 5.5k 1.4× 5.7k 1.7× 2.3k 0.8× 245 20.7k
Tetsuya Suhara Japan 67 6.0k 0.7× 3.8k 0.9× 3.1k 0.8× 3.9k 1.2× 1.7k 0.6× 435 17.0k
Anissa Abi‐Dargham United States 73 9.9k 1.2× 4.1k 0.9× 6.1k 1.6× 6.3k 1.9× 2.5k 0.8× 228 19.2k
Lars Farde Sweden 82 11.2k 1.3× 5.1k 1.2× 7.5k 2.0× 5.7k 1.7× 2.6k 0.8× 467 24.2k
Sylvain Houle Canada 94 8.5k 1.0× 3.6k 0.8× 4.8k 1.3× 10.5k 3.2× 3.3k 1.1× 421 28.1k
Sami S. Zoghbi United States 61 6.1k 0.7× 3.6k 0.8× 2.3k 0.6× 1.8k 0.5× 1.7k 0.5× 271 14.2k
Carol A. Tamminga United States 83 7.8k 0.9× 5.6k 1.3× 8.2k 2.1× 7.4k 2.2× 1.9k 0.6× 503 23.2k
John Seibyl United States 66 6.3k 0.8× 3.1k 0.7× 4.6k 1.2× 3.5k 1.1× 1.3k 0.4× 312 17.0k

Countries citing papers authored by Alan A. Wilson

Since Specialization
Citations

This map shows the geographic impact of Alan A. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan A. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan A. Wilson more than expected).

Fields of papers citing papers by Alan A. Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan A. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan A. Wilson. The network helps show where Alan A. Wilson may publish in the future.

Co-authorship network of co-authors of Alan A. Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Alan A. Wilson. A scholar is included among the top collaborators of Alan A. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan A. Wilson. Alan A. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Setiawan, Elaine, Sophia Attwells, Alan A. Wilson, et al.. (2018). Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. The Lancet Psychiatry. 5(4). 339–347. 163 indexed citations
2.
Andreazza, Ana C., Celine Teo, Alan A. Wilson, et al.. (2016). Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 72. 23–29. 11 indexed citations
3.
Caravaggio, Fernando, Carol Borlido, Alan A. Wilson, & Ariel Graff‐Guerrero. (2015). Examining endogenous dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission tomography: A pilot study. Clinica Chimica Acta. 449. 60–62. 27 indexed citations
4.
Kolla, Nathan J., Alan A. Wilson, Sylvain Houle, et al.. (2014). Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition. Biological Psychiatry. 79(2). 117–126. 32 indexed citations
5.
Rekkas, P. Vivien, Alan A. Wilson, Julia Sacher, et al.. (2014). Greater Monoamine Oxidase A Binding in Perimenopausal Age as Measured With Carbon 11–Labeled Harmine Positron Emission Tomography. JAMA Psychiatry. 71(8). 873–873. 58 indexed citations
6.
Hicks, Justin W., Oleg Sadovski, Jun Parkes, et al.. (2014). Radiosynthesis and ex vivo evaluation of [18F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET. Bioorganic & Medicinal Chemistry Letters. 25(2). 288–291. 16 indexed citations
7.
Boileau, Isabelle, Pablo Rusjan, Alan A. Wilson, et al.. (2013). Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [11C]-(+)-PHNO PET Study. PLoS ONE. 8(3). e60382–e60382. 11 indexed citations
8.
Vasdev, Neil, David E. Green, Douglass Vines, et al.. (2013). Positron-Emission Tomography Imaging of the TSPO with [ 18 F]FEPPA in a Preclinical Breast Cancer Model. Cancer Biotherapy and Radiopharmaceuticals. 28(3). 254–259. 18 indexed citations
9.
Boileau, Isabelle, Doris Payer, Sylvain Houle, et al.. (2012). Higher Binding of the Dopamine D 3 Receptor-Preferring Ligand [ 11 C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study. Journal of Neuroscience. 32(4). 1353–1359. 143 indexed citations
10.
Moran, Matthew, Alan A. Wilson, Charles S. Elmore, et al.. (2012). Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors. Bioorganic & Medicinal Chemistry. 20(14). 4482–4488. 22 indexed citations
11.
McCormick, Patrick N., Nathalie Ginovart, & Alan A. Wilson. (2010). Isoflurane Anaesthesia Differentially Affects the Amphetamine Sensitivity of Agonist and Antagonist D2/D3 Positron Emission Tomography Radiotracers: Implications for In Vivo Imaging of Dopamine Release. Molecular Imaging and Biology. 13(4). 737–746. 20 indexed citations
12.
Boileau, Isabelle, Pablo Rusjan, Sylvain Houle, et al.. (2008). Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker?. Journal of Neuroscience. 28(39). 9850–9856. 73 indexed citations
13.
Voineskos, Aristotle N., Alan A. Wilson, Sandra Sagrati, et al.. (2007). Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography. Psychopharmacology. 193(4). 539–545. 46 indexed citations
14.
Rabiner, Eugenii A., Roger Raymond, Mustansir Diwan, et al.. (2007). D3 and D2 components of ex vivo regional (+)-PHNO brain binding in wild-type and knock-out mice. 48(4). 205–12. 14 indexed citations
15.
Meyer, Jeffrey H., Heather E. McNeely, Sandra Sagrati, et al.. (2006). Elevated Putamen D 2 Receptor Binding Potential in Major Depression With Motor Retardation: An [ 11 C]Raclopride Positron Emission Tomography Study. American Journal of Psychiatry. 163(9). 1594–1602. 118 indexed citations
16.
Meyer, Jeffrey H., Sylvain Houle, Sandra Sagrati, et al.. (2004). Brain Serotonin Transporter Binding Potential Measured With Carbon11–Labeled DASB Positron Emission Tomography. Archives of General Psychiatry. 61(12). 1271–1271. 200 indexed citations
17.
Mamo, David C., Gary Remington, José N. Nóbrega, et al.. (2004). Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine. Synapse. 52(2). 153–162. 9 indexed citations
18.
Wilson, Alan A., Jean DaSilva, & Sylvain Houle. (1995). Synthesis of two radiofluorinated cocaine analogues using distilled 2-[18F]fluoroethyl bromide. Applied Radiation and Isotopes. 46(8). 765–770. 40 indexed citations
19.
Lew, Robert, Amrat Patel, Roxanne A. Vaughan, Alan A. Wilson, & M J Kuhar. (1992). Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens. Brain Research. 584(1-2). 266–271. 44 indexed citations
20.
O’Tuama, Lorcan A., Peter C. Phillips∥, Lewis C. Strauss, et al.. (1990). Two-phase [11C]l-methionine PET in childhood brain tumors. Pediatric Neurology. 6(3). 163–170. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026